Lupin’s Japanese arm to set up manufacturing plant in Japan

01 Mar 2016 Evaluate

Lupin’s wholly-owned Japanese subsidiary -- Kyowa Pharmaceutical Industry, is planning to set up a manufacturing plant at Tottori, Japan as part of expansion plans in the country. In order to meet the rapidly growing demand of generics, the company is planning to set-up two billion tablets capacity plant at Tottori, Japan which would be designed to efficiently handle mass volume products and provide flexibility in allowing easy future expansion. 

Lupin is an innovation led transnational pharmaceutical company producing and developing a wide range of branded & generic formulations, biotechnology products and APIs globally.

Lupin Share Price

2089.65 -0.50 (-0.02%)
16-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1782.80
Dr. Reddys Lab 1279.00
Cipla 1500.00
Zydus Lifesciences 913.90
Lupin 2089.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×